SCHEMBL5047159

SCHEMBL5047159

CCCCC(CC)COC(=O)C(C#N)=Cc1ccc(C(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.57
LMNA P02545 4/20 0.57
MAPK1 P28482 3/20 0.57
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
CYP3A4 P08684 2/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CA2 P00918 1/20 0.44
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5047156 1.00 ALDH1A1 (0.57) ALDH1A1LMNAMAPK1KDM4EMAPT
SCHEMBL10644154 0.93 ALDH1A1 (0.58) ALDH1A1LMNAMAPK1KDM4EMAPT
SCHEMBL7109919 0.90 ALDH1A1 (0.64) ALDH1A1LMNAMAPK1KDM4EMAPT
SCHEMBL7109914 0.90 ALDH1A1 (0.64) ALDH1A1LMNAMAPK1KDM4EMAPT
SCHEMBL2585864 0.88 ALDH1A1 (0.59) ALDH1A1LMNAMAPK1KDM4EMAPT
SCHEMBL2585860 0.88 ALDH1A1 (0.59) ALDH1A1LMNAMAPK1KDM4EMAPT
SCHEMBL4139254 0.88 ALDH1A1 (0.53) ALDH1A1LMNAMAPK1KDM4EMAPT
SCHEMBL2155616 0.88 ALDH1A1 (0.53) ALDH1A1LMNAMAPK1KDM4EMAPT
SCHEMBL4139257 0.88 ALDH1A1 (0.53) ALDH1A1LMNAMAPK1KDM4EMAPT
SCHEMBL5408071 0.84 KDM4E (0.53) ALDH1A1LMNAMAPK1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414138-B2 Benzoxazole and benzodiazole UV-A sunscreens DSM IP ASSETS B.V. (NL) 2008-08-19 US disclosed
US-20050260144-A1 Benzoxazole and benzodiazole uv-a sunscreens DSM IP ASSETS B.V. (NL) 2005-11-24 US disclosed
EP-1515694-A1 BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS DSM IP Assets B.V. (NL) 2005-03-23 EP disclosed
WO-2004000256-A1 BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS DSM IP ASSETS B.V. (NL) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260144-A1 Benzoxazole and benzodiazole uv-a sunscreens SUN2, CYP27B1, ERCC4 ALDH1A1 249/4885LMNA 904/4885MAPK1 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.